<DOC>
	<DOCNO>NCT02021097</DOCNO>
	<brief_summary>The purpose study evaluate contraceptive efficacy safety oral contraceptive contain combination LNG 100mcg/EE 20mcg compare LNG 150mcg/EE 30 mcg .</brief_summary>
	<brief_title>Study Evaluating Levonorgestrel Ethinyl Estradiol Oral Contraception</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Healthy woman , age 2035 year wish use contraceptive . Women without reproductive system infection complication . Willingness use form hormonal treatment . Three regular menstrual cycle study ( 2135 day per cycle 37 day 's bleeding period , without amenorrhea irregular bleeding ) . Signed informed consent prior entry trial . Any contraindication use oral contraceptive . Vascular , metabolic , hepatic , renal , oncologic disease .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Levonorgestrel；</keyword>
	<keyword>Ethinyl Estradiol；</keyword>
	<keyword>Oral Contraceptive</keyword>
</DOC>